Cerebrovascular Disorders

Cerebrovascular disorder refers to the condition in which blood flow in the brain is blocked or limited for temporarily or permanently. It includes all disorders in which an area of the brain is affected by ischemia or bleeding. Restrictions in blood flow may occur from vessel narrowing clot formation, blockage or hemorrhage. Cerebrovascular disease can develop from a variety of causes such as atherosclerosis, embolic arterial blood clot, cerebral venous thrombosis, blood vessel damage, and hypertension. There are also many less common causes of cerebrovascular disease, including those that are congenital or idiopathic and include CADASIL, aneurysms, amyloid angiopathy, arteriovenous malformations, fistulas, and arterial dissections. 

Common symptoms include:

A severe and sudden headache
Hemiplegia
Hemiparesis
Confusion
Slurred speech
Vision loss on one side
loss of balance
Loss of conciousness
Sub-track

• Stroke
• Carotid stenosis
• Vertebral stenosis  
• Intracranial stenosis
• Cerebral aneurysm 
• Vascular malformations
• Psychological therapy
• Occupational therapy
• Emergency Medicine

Market Analysis: During the forecast period, the worldwide cerebrovascular disease treatment market is expected to develop at a significant CAGR of 5.9%. The advancement of technology and the rising occurrence of strokes are two main factors driving the growth of the cerebrovascular disease treatment market. The cerebrovascular disorders market may be divided into four key regions based on geography: North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America leads the global market for cerebrovascular illness, followed by Europe.  During the projected period 2021-2027, the global "Cerebrovascular Disease Market" is expected to develop at a stable rate.